Activation of the EBV/C3D receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3167-3173

  Barel, M ^a   Romancer, M L ^a   Frade, R ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; COMPLEMENT COMPONENT C3D RECEPTOR; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; NUCLEOLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTYROSINE; PROTEIN ANTIBODY; PROTEIN GAB1; PROTEIN P85; PROTEIN P95; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE; SEPHAROSE; UNCLASSIFIED DRUG; VAV PROTEIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0035284732     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3167     Document Type: Article

References (56)

1. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody
2. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes
3. Gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4)
4. Isolation and characterization of a C3b receptor-like molecule from membranes of a human B lymphoblastoid cell line (Raji)
5. Mapping of the C3d receptor (CR2)-binding site and neoantigenic site in the C3d domain of the third component of complement
6. Signal transduction through the Epstein-Barr virus receptor in human B lymphocytes
7. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2
8. Gp140, the C3d receptor (CR2) of human B lymphocytes, is also the EBV receptor
9. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
10. Monoclonal and anti-idiotypic anti-EBV/C3d receptor (EBV/C3dR) antibodies detect two distinct binding sites, one for Epstein-Barr virus and one for C3d on gp140 the EBV/C3dR, expressed on human B lymphocytes
11. Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2
12. Analysis of Epstein-Barr virus binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides: At least two binding sites are necessary for ligand-receptor interaction
13. Autoantibodies against gp140, the Epstein-Barr virus and C3d receptor in sera from rheumatoid arthritis patients
14. CD21 is a ligand for CD23 and regulates IgE production
15. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes
16. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members ofthe family of C3/C4 binding proteins
17. C3 stimulates proliferation of human pre B Raji cells
18. Enhancement of human B cell proliferation by antibody to the C3d receptor, the gp140 molecule
19. Binding of monoclonal antibody to the Epstein Barr Virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes
20. Growth control of activated, synchronised murine B cells by the C3d fragment of human complement
21. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction
22. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes
23. Intersection of the complement and immune systems: A signal transduction complex of the B lymphocytes containing complement receptor type 2 and CD19
24. The CD19/CD21 signal transducing complex of human B lymphocyte includes the target of antiproliferative antibody-1 and leu-13 molecules
25. Functional dissection of CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes
26. Gp 140, the EBV/C3d receptor (CR2) is phosphorylated upon in vitro activation of human pefipheral B lymphocytes
27. Tissue specific phosphorylation of CR1 and CR2
28. Enhancement of Epstein-Barr virus/C3d receptor (EBV/C3dR or CR2) and nuclear p120 ribonucleo-protein phosphorylation by specific EBV/C3d ligands in subcellular fraction of the human B lymphoma cell line, Raji
29. Epstein-Barr virus/C3d receptor (EBV/C3d R) reacts with p53, a cellular anti-oncogene encoded membrane phosphoprotein: Detection by polyclonal anti-idiotypic anti-EBV/C3dR antibodies (Ab2)
30. Intracellular interaction of Epstein-Barr virus receptor with p68, a calcium binding protein, present in normal and not in transformed B lymphocytes
31. Gp140, the EBV/C3d receptor (CR2) of human B lymphocytes is involved in cell-free phosphorylation of p120, a nuclear ribonucleoprotein
32. EBV/C3d receptor (CR2) interacts by its intracytoplasmic carboxy-terminal domain and two distinct binding sites with the p53 anti-oncoprotein and the p68 calcium binding protein
33. Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein
34. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection
35. Pep34, a synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the Epstein-Barr virus receptor (CR2, CD21), regulates B lymphocyte proliferation triggered through CR2
36. A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphorylation of transformed CR2 positive human lymphocytes and of normal resting B lymphocytes
37. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells
38. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulares pp 105 phosphorylation through two distinct pathways
39. Signaling through the EBV/C3d receptor (CR2/CD21) in human B lymphocytes: Activation of phosphatidylinositol 3-kinase via a CD19-independent pathway
40. Molecular dissection of nucleolin's role in growth and cell proliferation: New insights
41. Nucleocytoplasmic transport: Signals, mechanisms and regulation
42. Cellular adhesion mediated by factor J, a complement inhibitor: Evidence for nucleolin involvement
43. Interrelations between the maturation of a 100 kDa nucleolar protein and pre rRNA synthesis in CHO cells
44. Nucleolin is one component of the B cell specific transcription factor and switch region binding protein, LR1
45. Phosphorylation of nucleolin by a nucleolar type N11 protein kinase
46. Protein kinase N11 and the regulation of rDNA transcription in mammalian cells
47. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase
48. Interaction of the p85 subunit of P1 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: Structural features and analysis of conformational changes
49. Mechanisms and consequences of activation of protein kinase B/Akt
50. CD19-dependent activation of Akt kinase in B lymphocytes
51. Identification of a 10-amino acid proline-rich SH3 binding site
52. Pleckstrin homology domains
53. Immunomodulatory functions of murine CR1/2
54. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase
55. Activation of phosphatidylinositol-3′ kinase by src-family kinase SH3 binding to the p85 subunit
56. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B